Skip to main content

Table 3 Cannabis substitution for pharmaceuticals among 275 Michigan medical cannabis patients, influences for substitution, and primary care provider knowledge of substitution

From: Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution

   

Influences for substitution (%)

Substance type

Use n (%)

Substitution (%)

Experiences

Healthcare provider

Dispensary

Individuals

Other

Amphetamines

52 (19%)

75

89

11

0

3

14

Anticonvulsants

30 (13%)

70

87

22

4

8

4

Antidepressants

141 (51%)

53

93

22

7

6

6

Antiemetics

33, 12%

79

87

13

4

0

4

Antihistamines

94, 34%

36

100

3

0

3

6

Antipsychotics

19 (7%)

78

71

43

0

7

0

Anxiolytics or benzodiazepines

64 (23%)

73

87

34

4

8

8

Muscle relaxers

107 (39%)

82

88

15

3

5

11

Non-opioid pain relievers

93 (34%)

76

97

10

4

6

12

Nonsteroidal anti-inflammatories

125 (46%)

62

92

14

3

4

9

Opioids

102 (37%)

86

88

28

11

9

12

Non-amphetamine stimulants

19 (7%)

50

89

11

0

11

22

Prescription cannabinoids

5 (2%)

75

75

0

0

25

25

Sedatives

34 (12%)

88

93

25

7

4

14

Sleep aids

79 (29%)

83

95

15

6

8

5

Steroids

44 (16%)

64

55

18

2

0

2

  1. N = 275 participants total, 192 of whom reported any substitution. Note: all values are proportions of relevant groups. Use indicates proportion of participants who have used a substance. Substitution indicates proportion of participants using a substance who have reduced or stopped their use because of medical cannabis. Influences for substitution include participant’s own experimentation and experiences, advice from primary health/medical care provider, advice from my medical marijuana caregiver/dispensary, advice from other individual(s), and other source of information
  2. PCP primary care provider